US Patent 7964610 Buprenorphine derivatives and uses thereof

Patent 7964610 was granted and assigned to Reckitt Benckiser on June, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Reckitt Benckiser

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7964610

Patent Inventor Names

John William Lewis0

Christopher Bourne Chapleo0

Date of Patent

June 21, 2011

Patent Application Number

12294462

Date Filed

March 27, 2007

Patent Primary Examiner

‌

Charanjit Aulakh

Patent abstract

Ester derivatives of the phenolic hydroxyl group of buprenorphine can be used in the treatment of opiate dependency and/or moderate to severe pain. The esters have an enhanced bioavailability, an enhanced duration of action, and a reduced abuse potential.